CVS Streamlines Specialty Drug Access
CVS Health's pharmacy benefit manager, CVS Caremark, has streamlined its prior authorization process for specialty medications. The Woonsocket-based company said the initiative is designed to accelerate patient access to treatments and reduce administrative burdens for healthcare providers. This move reflects an ongoing focus on operational efficiency and patient-centered care.
- The streamlined process utilizes Surescripts Touchless Prior Authorization, a technology that connects directly to a patient's electronic health record to automatically retrieve clinical data, which can lead to approvals in as little as 22 seconds. - Prior authorizations have been a significant administrative burden, with physicians and their staff spending an average of 12 hours per week on them; studies have shown that 94% of patients experience care delays due to the process. - This initiative specifically targets specialty drugs, the fastest-growing and most expensive segment of the pharmaceutical market, which is projected to reach $965.5 billion by 2030 and accounts for roughly 75% of drugs currently in development. - The first medications included in this accelerated process are Vivitrol, for substance use disorder, and Epidiolex, used for treating epilepsy, indicating a focus on therapies with complex approval requirements. - As one of the three largest pharmacy benefit managers (PBMs) that collectively process nearly 80% of all U.S. prescription claims, CVS Caremark's operational changes can have a widespread impact on the healthcare system. - Administrative complexity is a major driver of U.S. healthcare costs, accounting for up to 30% of total spending, a figure that initiatives like this aim to reduce. - As a major local employer, CVS Health's operational efficiencies are significant for the regional economy; in fiscal year 2024, the company generated a $3.4 billion economic impact in Rhode Island and supported over 17,900 jobs. - This change is part of a larger company strategy to simplify health insurance, with its Aetna unit aiming to standardize 50 of the most common prior authorization procedures by the end of 2026.
